Eisler Capital (US)’s Zai Lab ZLAB Stock Holding History

Eisler Capital (US)’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-44,234	Closed	-$709K	–	703
2024 Q1	$709K	Buy	+44,234	New	+$932K	0.02%	446

Other funds holding ZLAB

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Eisler Capital (US)'s ZLAB Position: Q2 2024 in Review

Eisler Capital (US) sold out of Zai Lab (ZLAB) in Q2 2024, closing a stake of 44,234 shares — an estimated $709K sold.

Eisler Capital (US) first reported a position in ZLAB in Q1 2024 and held it in 1 quarter. The position peaked at $709K in Q1 2024. 105 funds tracked by Wall St. Rank hold ZLAB as of Q2 2024.

Eisler Capital (US) reported no remaining Zai Lab position as of Q2 2024 after selling out during the quarter.
Eisler Capital (US) sold 44,234 Zai Lab shares in Q2 2024, an estimated $709K.
Eisler Capital (US) first reported a position in Zai Lab in Q1 2024 and held it in 1 quarter.
Eisler Capital (US)'s Zai Lab position peaked at $709K in Q1 2024.
105 funds tracked by Wall St. Rank held Zai Lab as of Q2 2024.

Based on Eisler Capital (US)'s 13F filing for Q2 2024, filed 13 Aug 2024.